146 related articles for article (PubMed ID: 36625768)
1. Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity.
Němec V; Khirsariya P; Janovská P; Moyano PM; Maier L; Procházková P; Kebková P; Gybel' T; Berger BT; Chaikuad A; Reinecke M; Kuster B; Knapp S; Bryja V; Paruch K
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217532. PubMed ID: 36625768
[TBL] [Abstract][Full Text] [Related]
2. 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors.
Hua Z; Huang X; Bregman H; Chakka N; DiMauro EF; Doherty EM; Goldstein J; Gunaydin H; Huang H; Mercede S; Newcomb J; Patel VF; Turci SM; Yan J; Wilson C; Martin MW
Bioorg Med Chem Lett; 2012 Sep; 22(17):5392-5. PubMed ID: 22877629
[TBL] [Abstract][Full Text] [Related]
3. Targeting Casein Kinase 1 (CK1) in Hematological Cancers.
Janovská P; Normant E; Miskin H; Bryja V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261128
[TBL] [Abstract][Full Text] [Related]
4. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
5. Achieving effective and selective CK1 inhibitors through structure modification.
Du C; Yang H; Feng F; Liu W; Chen Y; Sun H
Future Med Chem; 2021 Mar; 13(5):505-528. PubMed ID: 33438471
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Development of Casein Kinase 1 Inhibitors.
Li SS; Dong YH; Liu ZP
Curr Med Chem; 2021; 28(8):1585-1604. PubMed ID: 32660395
[TBL] [Abstract][Full Text] [Related]
7. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
9. The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms.
Fulcher LJ; Bozatzi P; Tachie-Menson T; Wu KZL; Cummins TD; Bufton JC; Pinkas DM; Dunbar K; Shrestha S; Wood NT; Weidlich S; Macartney TJ; Varghese J; Gourlay R; Campbell DG; Dingwell KS; Smith JC; Bullock AN; Sapkota GP
Sci Signal; 2018 May; 11(531):. PubMed ID: 29789297
[TBL] [Abstract][Full Text] [Related]
10. Casein kinase 1α has a non-redundant and dominant role within the CK1 family in melanoma progression.
Sinnberg T; Wang J; Sauer B; Schittek B
BMC Cancer; 2016 Aug; 16():594. PubMed ID: 27488834
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δ.
Choi JY; Noguchi Y; Alburger JM; Bayle S; Chung E; Grant W; Chaikuad A; Knapp S; Duckett DR; Roush WR
J Med Chem; 2023 Jun; 66(11):7162-7178. PubMed ID: 37204207
[TBL] [Abstract][Full Text] [Related]
12. Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.
Oumata N; Bettayeb K; Ferandin Y; Demange L; Lopez-Giral A; Goddard ML; Myrianthopoulos V; Mikros E; Flajolet M; Greengard P; Meijer L; Galons H
J Med Chem; 2008 Sep; 51(17):5229-42. PubMed ID: 18698753
[TBL] [Abstract][Full Text] [Related]
13. Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.
Yang LL; Li GB; Yan HX; Sun QZ; Ma S; Ji P; Wang ZR; Feng S; Zou J; Yang SY
Eur J Med Chem; 2012 Oct; 56():30-8. PubMed ID: 22944772
[TBL] [Abstract][Full Text] [Related]
14. Zebrafish as model system for the biological characterization of CK1 inhibitors.
Meier L; Gahr BM; Roth A; Gihring A; Kirschner S; Woitaske-Proske C; Baier J; Peifer C; Just S; Knippschild U
Front Pharmacol; 2023; 14():1245246. PubMed ID: 37753113
[No Abstract] [Full Text] [Related]
15. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
[TBL] [Abstract][Full Text] [Related]
16. The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development.
Knippschild U; Wolff S; Giamas G; Brockschmidt C; Wittau M; Würl PU; Eismann T; Stöter M
Onkologie; 2005 Oct; 28(10):508-14. PubMed ID: 16186692
[TBL] [Abstract][Full Text] [Related]
17. Functions and regulation of the serine/threonine protein kinase CK1 family: moving beyond promiscuity.
Fulcher LJ; Sapkota GP
Biochem J; 2020 Dec; 477(23):4603-4621. PubMed ID: 33306089
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
[TBL] [Abstract][Full Text] [Related]
19. Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors.
Wager TT; Galatsis P; Chandrasekaran RY; Butler TW; Li J; Zhang L; Mente S; Subramanyam C; Liu S; Doran AC; Chang C; Fisher K; Grimwood S; Hedde JR; Marconi M; Schildknegt K
ACS Chem Neurosci; 2017 Sep; 8(9):1995-2004. PubMed ID: 28609096
[TBL] [Abstract][Full Text] [Related]
20. CK1 in Developmental Signaling: Hedgehog and Wnt.
Jiang J
Curr Top Dev Biol; 2017; 123():303-329. PubMed ID: 28236970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
